Characteristics |
Death with COVID-19, OR (95% CI) |
p-Value |
Death
with COVID-19, OR (95% CI) |
p-Value |
Age, median, years |
1.06 (1.04-1.08) |
< 0.001 |
1.64 (1.23-2.19) |
0.001 |
Sex |
Sex |
Sex |
Sex |
Sex |
Male
|
1.54 (0.92-2.59)
|
0.101
|
1.54 (0.81-2.93)
|
0.189
|
Female
|
Ref
|
|
Ref
|
|
Weighted Charlson comorbidity index |
Weighted Charlson comorbidity
index |
Weighted Charlson comorbidity index |
Weighted Charlson
comorbidity index |
Weighted Charlson comorbidity index |
0
|
Ref
|
|
Ref
|
|
1
|
3.15 (0.69-14.48)
|
0.140
|
1.78 (0.36-8.76)
|
0.476
|
2
|
4.45 (0.95-20.91)
|
0.058
|
1.67 (0.31-8.98)
|
0.548
|
>3
|
13.81 (3.19-59.86)
|
<0.001
|
5.20 (0.93-29.18)
|
0.061
|
Comorbidities within the Charlson comorbidity index |
Comorbidities
within the Charlson comorbidity index |
Comorbidities within the
Charlson comorbidity index |
Comorbidities within the Charlson
comorbidity index |
Comorbidities within the Charlson comorbidity
index |
Myocardial infarction
|
4.09 (2.04-8.20)
|
<0.001
|
3.57 (1.49-8.56)
|
0.004
|
Congestive heart failure
|
2.24 (1.20-4.20)
|
0.012
|
0.85 (0.35-2.11)
|
0.733
|
Cerebrovascular disase
|
1.51 (0.87-2.62)
|
0.141
|
1.05 (0.50-2.21)
|
0.898
|
Chronic pulmonary disease
|
1.532 (0.449-5.223)
|
0.496
|
1.26 (0.22-7.09)
|
0.796
|
Ulcer disease
|
4,986,033,534
|
0.999
|
|
|
Mild liver disease
|
4,925,228,246
|
1.000
|
|
|
Diabetes mellitus
|
2.46 (1.48-4.10)
|
0.001
|
2.41 (1.17-4.97)
|
0.017
|
Hemiplegia
|
0.000
|
0.999
|
|
|
Renal disease
|
6.01 (2.95-12.21)
|
<0.001
|
5.18 (2.07-12.97)
|
<0.001
|
Diabetes wih end organ damage
|
0.000
|
0.999
|
|
|
Any malignancy
|
0.000
|
0.999
|
|
|
AIDS
|
6.15 (0.55-68.69)
|
0.140
|
13.41 (0.85-210.70)
|
0.065
|
Length of stay, median, day |
1.10 (1.03-1.18) |
0.004 |
1.20 (1.08-1.32) |
<0.001 |